1. Home
  2. WOLF vs EYPT Comparison

WOLF vs EYPT Comparison

Compare WOLF & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

HOLD

Current Price

$21.34

Market Cap

838.3M

Sector

Technology

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.73

Market Cap

967.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOLF
EYPT
Founded
1987
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
838.3M
967.4M
IPO Year
1993
2005

Fundamental Metrics

Financial Performance
Metric
WOLF
EYPT
Price
$21.34
$13.73
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$10.50
$29.60
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$759,700,000.00
$42,339,000.00
Revenue This Year
$16.42
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.05
$3.91
52 Week High
$36.60
$14.96

Technical Indicators

Market Signals
Indicator
WOLF
EYPT
Relative Strength Index (RSI) 53.22 54.51
Support Level $16.47 $13.43
Resistance Level $23.12 $14.96
Average True Range (ATR) 1.69 0.87
MACD 0.45 0.14
Stochastic Oscillator 75.46 65.57

Price Performance

Historical Comparison
WOLF
EYPT

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: